Silo Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Sarasota, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Silo Pharma, Inc. has filed 376 SEC EDGAR filings since 30 Mar 2011

SEC filing history

Showing 76-100 of 376 matching filings.

Per page
25
Current page
4
DRS File 377-07881

DRS filing

Filing date
11 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-281692

PROSPECTUS

Filing date
04 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-281692

EFFECT filing

Filing date
03 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-281692

POST-EFFECTIVE AMENDMENT TO FORM S-1

Filing date
28 Mar 2025
Reporting date
Not listed
Next action
Verify source filing
10-K File 001-41512

ANNUAL REPORT

Filing date
28 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
8-K File 001-41512

CURRENT REPORT

Filing date
10 Mar 2025
Reporting date
10 Mar 2025
Next action
Verify source filing
8-K File 001-41512

CURRENT REPORT

Filing date
07 Mar 2025
Reporting date
04 Mar 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-87110

SCHEDULE 13G/A filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41512

CURRENT REPORT

Filing date
02 Jan 2025
Reporting date
02 Jan 2025
Next action
Verify source filing
8-K File 001-41512

CURRENT REPORT

Filing date
20 Dec 2024
Reporting date
20 Dec 2024
Next action
Verify source filing
4

4 filing

Filing date
16 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2024
Reporting date
20 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFR14A File 001-41512

PROXY STATEMENT

Filing date
15 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-87110

SCHEDULE 13G filing

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41512

QUARTERLY REPORT

Filing date
12 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
DEFA14A File 001-41512

CURRENT REPORT

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41512

CURRENT REPORT

Filing date
08 Nov 2024
Reporting date
08 Nov 2024
Next action
Verify source filing
ARS File 001-41512

ANNUAL REPORT

Filing date
18 Sep 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41512

ADDITIONAL DEFINITIVE SOLICITING MATERIALS.

Filing date
18 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41512

PROXY STATEMENT

Filing date
18 Sep 2024
Reporting date
12 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41512

CURRENT REPORT

Filing date
10 Sep 2024
Reporting date
10 Sep 2024
Next action
Verify source filing
424B3 File 333-281692

PROSPECTUS

Filing date
04 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-281692

EFFECT filing

Filing date
03 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-281692

UPLOAD filing

Filing date
28 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .